While these effects have been demonstrated in multiple tumor cell lines, the absence of p53 in the platelet proteome [117] as well as the lack of a functional genome in platelets suggests that p53 acetylation will have minimal impact on platelet biology. The gene discussed is TP53; the disease is neoplasm.